Therapeutic effect of adenoviral-mediated hepatocyte growth factor gene administration on TNBS-induced colitis in mice

Biochemical and Biophysical Research Communications

Volumn 329, Issue 4, 2005, Pages 1217-1224

  Mukoyama, Tomoyuki ^a,b   Kanbe, Takamasa ^a   Murai, Rie ^a   Murawaki, Yoshiyuki ^b   Shimomura, Takashi ^a   Hashiguchi, Ko Ichi ^a   Saeki, Toshiya ^a   Ichiba, Miho ^a   Yoshida, Yoko ^a   Tanabe, Naotada ^a   Kurimasa, Akihiro ^a   Harada, Ken Ichi ^b   Yashima, Kazuo ^b   Hisatome, Ichiro ^a   Ito, Hisao ^c   Murawaki, Yoshikazu ^b   Shiota, Goshi ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

Author keywords

Adenovirus; Gene therapy; Hepatocyte growth factor; TNBS colitis

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SCATTER FACTOR; SODIUM CHLORIDE; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE EXPRESSION; INTESTINE EPITHELIUM CELL; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE;

EID: 20244373623     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.01.166     Document Type: Article

References (29)

1. S. Wirtz, and M.F. Neurath Gene transfer approaches for the treatment of inflammatory bowel disease Gene Therapy 20 2003 854 860
2. G. Shiota, T. Kunisada, K. Oyama, A. Udagawa, T. Nomi, K. Tanaka, A. Tsutsumi, M. Isono, T. Nakamura, H. Hamada, T. Sakatani, S. Sell, K. Sato, H. Ito, and H. Kawasaki In vivo transfer of hepatocyte growth factor gene accelerates proliferation of hepatic oval cells in a 2-acetylaminofluorene/ partial hepatectomy model in rats FEBS Lett. 470 2000 325 330
3. M.F. DiRenzo, R.P. Narsimhan, and M. Oliver Expression of the Met/HGF receptor in normal and neoplastic human tissues Oncogene 6 1991 1997 2003
4. A.U. Dignass, D.K. Lynch, and D.K. Podolsky Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration Biochem. Biophys. Res. Commun. 202 1994 701 709
5. M. Goke, M. Kanai, and D.K. Podolsky Intestinal fibroblasts regulate intestinal epithelial cell proliferation via hepatocyte growth factor Am. J. Phys. 274 1998 G809 G818
6. Y. Kinoshita, H. Nakata, S. Hassan, M. Asahara, C. Kawanomi, and Y. Matsushima Gene expression of keratinocyte and hepatocyte growth factors during the healing of rat gastric mucosal lesions Gastroenterology 109 1995 1068 1077
7. W. Kong, L.F. Yee, and S.J. Mulvihill Hepatocyte growth factor stimulates fetal gastric epithelial cell growth in vitro J. Surg. Res. 78 1998 161 168
8. M. Takahashi, S. Ota, T. Shimada, E. Hamada, T. Kawabe, T. Okudaira, et al., Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture, J. Clin. Invest. 95 (195) 1994-1996
9. K. Hori, G. Shiota, and H. Kawasaki Expression of hepatocyte growth factor and c-met receptor in gastric mucosa during gastric ulcer healing Scand. J. Gastroenterol. 35 2000 24 31
10. M. Matsuno, G. Shiota, K. Umeki, H. Kawasaki, H. Kojo, and K. Miura Induction of plasma hepatocyte growth factor in acute colitis of mice Inflamm. Res. 46 1997 166 167
11. L.G. Arthur, M.Z. Schwartz, K.A. Kuenzler, and R. Birbe Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease J. Pediatr. Surg. 39 2004 139 143
12. Y. Tahara, A. Ido, S. Yamamoto, Y. Miyata, H. Uto, T. Hori, K. Hayashi, and H. Tsubouchi Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats J. Pharmacol. Exp. Ther. 307 2004 146 151
13. S. Nishimura, M. Takahashi, S. Ota, M. Hirano, and H. Hirahashi Hepatocyte growth factor accelerates restitution of intestinal epithelial cells J. Gastroenterol. 33 1998 172 178
14. A. Keith, L. Kuenzler, G. Arthur, and M.Z. Schwartz A possible mechanism for prevention of intestinal programmed cell death after ischemia-reperfusion injury by hepatocyte growth factor pretreatment J. Pediatr. Surg. 37 2002 1696 1699
15. S. Miyake, M. Makimura, Y. Kanegae, S. Harada, Y. Sato, K. Takamori, C. Tokuda, and I. Saito Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome Proc. Natl. Acad. Sci. USA 93 1996 1320 1324
16. M.F. Neurath, I. Fuss, B.L. Kelsall, E. Stuber, and W. Strober Antibodies to interleukin 12 abrogate established experimental colitis in mice J. Exp. Med. 182 1995 1281 1290
17. B. Straub, M. Muller, H. Kraus, M. Schrader, C. Goessl, R. Heicappell, and K. Miller Detection of prostate-specific antigen RNA before and after radical retropublic prostatectomy and transurethral resection of the prostate using "Light-cycler" based quantitative real-time polymerase chain reaction Urology 58 2001 815 820
18. G.P. Morris, M.L. Beck, M.S. Herridge, W.T. Depew, M.R. Szewczuk, and J.L. Wallace Hapten-induced model of colonic inflammation and ulceration in the rat colon Gastroenterology 96 1989 795 803
19. T. Yamada, S. Marshall, R.D. Specian, and M.B. Grisham A comparative analysis of two models of colitis in rats Gastroenterology 102 1992 1524 1534
20. E. Marshman, G. Booth, and C.S. Potten The intestinal epithelial stem cell BioEssays 24 2002 91 98
21. D.K. Podolsky Inflammatory bowel disease N. Engl. J. Med. 347 2002 417 429
22. F. Shanahan Crohn's disease Lancet 359 2002 62 69
23. M.F. Neurath, S. Pettersson, K.-H. Meyer zum Buschenfelde, and W. Strober Local administration of antisense phosphothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice Nat. Med. 2 1996 998 1004
24. T. Nomi, G. Shiota, M. Isono, K. Sato, and H. Kawasaki Adenovirus-mediated hepatocyte growth factor gene transfer prevents lethal liver failure in rats Biochem. Biophys. Res. Commun. 278 2000 338 343
25. R.H.J.R. Collins, M. Feldman, and J.S. Fordtran Colon cancer, dysplasia and surveillance in patients with ulcerative colitis, a critical review N. Engl. J. Med. 316 1987 1654 1658
26. S. Kitamura, S. Kondo, Y. Shimomura, K. Isozaki, S. Kanayama, Y. Higashimoto, T. Minami, T. Kiyohara, Y. Yasunaga, and H. Ishikawa Expression of hepatocyte growth factor and c-met in ulcerative colitis Inflamm. Res. 49 2000 320 324
27. H. Ogata, and T. Hibi Cytokine and anti-cytokine therapies for inflammatory bowel disease Curr. Pharm. Des. 9 2003 1107 1113
28. P. Rutgeerts, G. Van Assche, and S. Vermeire Optimizing anti-TNF treatment in inflammatory bowel disease Gastroenterology 126 2004 1593 1610
29. M. Watanabe, M. Yamazaki, and T. Kanai Mucosal T cells as a target for treatment of IBD J. Gastroenterol. 38 2003 48 50